Pharmacological inhibition of the interleukin‐1 receptor‐associated kinase prevents angiotensin II‐induced cardiac remodelling in mice

Key Result

The IRAK-1/4 inhibitor prevented angiotensin II-induced cardiac remodeling in mice by reducing inflammation, fibrosis, and hypertrophy via TLR4-NF-κB and TGFβ-SMAD pathways.

Key Points

• This research aims to investigate the effect of IRAK-1/4 inhibition on cardiac remodeling induced by angiotensin II.
• Used a pharmacological inhibitor targeting IRAK-1/4 in a mouse model.
• Analyzed cardiac inflammation, fibrosis, and hypertrophy.
• Examined the involvement of TLR4-NF-κB and TGFβ-SMAD signaling pathways.
• IRAK-1/4 inhibition significantly reduced markers of cardiac inflammation.
• The treatment lowered fibrosis and hypertrophy in cardiac tissue.
• Inhibition affected both TLR4-NF-κB and TGFβ-SMAD pathways, indicating a mechanism for its effects.